Sculptra Treatments

At Kyle Farr Aesthetics, we offer Sculptra—an advanced injectable biostimulant designed to rejuvenate your appearance by stimulating your body’s own collagen production. Unlike traditional dermal fillers that provide instant volume, Sculptra works gradually and naturally to restore facial fullness, smooth wrinkles, and improve skin tone and texture over time. The result? A refreshed, youthful look that can last up to two years or more.

BOOK NOW

Restore Volume and Collagen Naturally

While dermal fillers like hyaluronic acid (HA) provide immediate plumping, Sculptra works differently. It’s made from poly-L-lactic acid (PLLA)—a biocompatible substance that stimulates collagen production deep within the skin. This collagen remodeling process gradually restores lost volume and improves skin texture, firmness, and elasticity over several weeks.

Sculptra is ideal for treating:


  • Hollowed temples
  • Sunken cheeks
  • Nasolabial folds (smile lines)
  • Marionette lines
  • Skin laxity, tone, and texture


Because results develop gradually, Sculptra offers a more subtle, natural transformation—perfect for patients who prefer progressive rejuvenation that continues to improve long after their appointment.

FAQS

  • When will I see results?

    Results from Sculptra develop gradually over several weeks as your body produces new collagen. Most patients begin to notice visible improvement within 4–8 weeks after their first session.

  • How long do Sculptra results last?

    Sculptra can last up to two years or longer, depending on your body’s collagen response and maintenance schedule.

  • Is there any downtime with a Sculptra treatment?

    Downtime is minimal. You may experience slight swelling or tenderness at the injection sites, but these effects usually resolve within a few days.

  • How many treatments of Sculptra will I need?

    Most patients need a series of 2–3 treatments, spaced about 4–6 weeks apart, to achieve optimal results. Maintenance sessions can help prolong your outcome.